Venous Phase Timing Does Not Predict SPECT Results During Balloon Test Occlusion of the Internal Carotid Artery

Brian M Snelling1, Samir Sur1, Sumedh S Shah1

  • 1Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.

World Neurosurgery
|March 20, 2017
PubMed

Insights

Venous phase timing did not correlate with SPECT findings in predicting hypoperfusion after internal carotid artery (ICA) occlusion. Further research is needed to identify reliable methods for assessing risks before carotid sacrifice.

Area of Science:

  • Neurology
  • Radiology
  • Vascular Surgery

Background:

  • Internal carotid artery (ICA) sacrifice is a treatment option for certain cerebrovascular conditions.
  • Predicting potential complications like hypoperfusion is crucial before vessel sacrifice.
  • Technetium-99m Single Photon Emission Computed Tomography (SPECT) is used to assess cerebral blood flow.

Purpose of the Study:

  • To evaluate the correlation between venous phase timing and SPECT findings.
  • To determine the predictive value of venous phase timing for hypoperfusion during balloon test occlusion of the ICA.
  • To assess the safety of subsequent ICA sacrifice based on these tests.

Main Methods:

  • Fifty-six patients undergoing balloon test occlusion of the ICA were studied.
  • Venous phase timing was calculated, and SPECT imaging was performed.
  • Patients were grouped based on SPECT findings: No Hypoperfusion, Mild Hypoperfusion, and Moderate/Severe Hypoperfusion.

Main Results:

  • No significant difference in venous phase timing was found across the three hypoperfusion groups (P = 0.22).
  • Patients with no hypoperfusion had an average venous delay of 0.65 seconds.
  • Patients with moderate/severe hypoperfusion had a longer average venous delay of 1.08 seconds.

Conclusions:

  • Venous phase timing does not correlate with SPECT findings in predicting hypoperfusion after ICA balloon occlusion.
  • Current methods may not be sufficient to predict delayed ischemia following carotid occlusion.
  • Additional studies are required to identify optimal adjunctive measures for risk assessment before ICA sacrifice.
Abstract